SEngine CEO and chief scientific officer Carla Grandori. (SEngine Photo) Seattle startup SEngine Precision Medicine has raised $10 million to propel drug discovery and development and advance its test that tailors drugs to cancer patients. SEngine cultures patient cancer cells from a biopsy or other material and measures the response to an array of potential…
